Please assess the completion status of the following clinical trial:

Trial Title: Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age older than 18~* Pre- or post-menopausal women with Stage I and II breast cancer, triple negative tumors~* Biopsy-proven invasive breast cancer, excised with negative margins of at least 1 mm~* Status post segmental mastectomy, after sentinel node biopsy and/or axillary node dissection (Tumors \< 5 mm in size do not require nodal assessment) or after mastectomy~* No previous chemotherapy~* Patient needs to be able to understand and demonstrate willingness to sign a written informed consent document~Exclusion Criteria:~* Previous radiation therapy to the ipsilateral breast~* Active connective tissue disorders, such as lupus or scleroderma~* Pregnant or lactating women

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ChemoRT (Type: EXPERIMENTAL): Concurrent Carboplatin and Radiotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).